Statistics from Altmetric.com
Competing interests: Although all authors have previously received honoraria for speaking engagements or research support from various pharmaceutical and device companies in the diabetes field, we do not have any competing interests to declare regarding the present manuscript.
- continuous subcutaneous insulin infusion
- Diabetes Control and Complications Trial
- Epidemiology of Diabetes Interventions and Complications
- glucagon-like peptide 1
- multiple daily injections
- neutral protamine Hagedorn
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.